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Polyglutamine-Expanded Ataxin-7 Antagonizes
CRX Function and Induces Cone-Rod Dystrophy
in a Mouse Model of SCA7
dysarthria, ophthalmoplegia, hyperreflexia, spasticity,
and retinal dystrophy (Martin et al., 1994). An important
feature of SCA7, which allows it to be distinguished from
the more than ten other SCAs, is the retinal degenera-
tion. On funduscopic examination, degeneration of the
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sponsible for color vision, the earliest sign of SCA7 reti-University of Washington Medical Center
nal degeneration is asymptomatic dyschromatopsia,Seattle, Washington 98195
usually involving blue-yellow discrimination (Gouw et7 Department of Neurobiology and Anatomy
al., 1994). As the centrally located macula is particularly8 Department of Human Genetics
cone rich, SCA7 patients initially complain of problems9 Howard Hughes Medical Institute
with central vision instead of with peripheral vision, andUniversity of Utah
they typically develop central scotomas (Enevoldson etSalt Lake City, Utah 84112
al., 1994). As retinal disease progresses in SCA7, the10 Department of Ophthalmology
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Profound genetic anticipation in SCA7 led investiga-Washington University School of Medicine
tors to screen patients for polyglutamine tract expan-St. Louis, Missouri 63110
sions and then to identify an unstable CAG trinucleotide
repeat as the cause of the disorder (David et al., 1997;
Trottier et al., 1995). SCA7 is one of eight inherited neuro-
degenerative disorders caused by CAG/polyglutamineSummary
repeats that expand to cause disease (Zoghbi and Orr,
2000). Included in the CAG/polyglutamine repeat dis-Spinocerebellar ataxia type 7 (SCA7) is an autosomal
ease category are spinal and bulbar muscular atrophydominant disorder caused by a CAG repeat expansion.
(SBMA), Huntington’s disease (HD), dentatorubral-pal-To determine the mechanism of neurotoxicity, we pro-
lidoluysian atrophy (DRPLA), and four other forms ofduced transgenic mice and observed a cone-rod dys-
spinocerebellar ataxia (SCA1, 2, 3, and 6). The gene fortrophy. Nuclear inclusions were present, suggesting
SCA7 encodes a novel protein (ataxin-7) and normallythat the disease pathway involves the nucleus. When
contains a ten CAG repeat tract starting at codon num-yeast two-hybrid assays indicated that cone-rod ho-
ber 30. In affected patients, the CAG repeat tract ex-meobox protein (CRX) interacts with ataxin-7, we per-
pands to 37 to 250 triplets (David et al., 1997). Ataxin-
formed further studies to assess this interaction. We
7 has a functional nuclear localization signal at codons
found that ataxin-7 and CRX colocalize and coim- 378–393 and localizes preferentially to the nuclear com-
munoprecipitate. We observed that polyglutamine- partment of cells in the cerebellum, pons, and the inferior
expanded ataxin-7 can dramatically suppress CRX olive (Kaytor et al., 1999; Lindenberg et al., 2000). A
transactivation. In SCA7 transgenic mice, electropho- preferential nuclear localization for ataxin-7 is also ob-
retic mobility shift assays indicated reduced CRX bind- served in the retina, where ataxin-7 protein appears to
ing activity, while RT-PCR analysis detected reduc- be highly expressed in photoreceptor cell nuclei (Lin-
tions in CRX-regulated genes. Our results suggest that denberg et al., 2000).
CRX transcription interference accounts for the retinal To understand the mechanism of polyglutamine neu-
degeneration in SCA7 and thus may provide an expla- rotoxicity in SCA7, we produced transgenic mice that
nation for how cell-type specificity is achieved in this express ataxin-7 with 24 or 92 glutamines throughout
polyglutamine repeat disease. the retina. We observed a cone-rod dystrophy type of
retinal degeneration in mice expressing ataxin-7 with 92
Introduction glutamines. Of the various genes known to cause cone-
rod dystrophy in humans, the gene for the cone-rod
Spinocerebellar ataxia type 7 (SCA7) is an autosomal homeobox protein (CRX) is the only one that encodes a
dominant disorder characterized by cerebellar ataxia, nuclear transcription factor containing a polyglutamine-
rich region (Chen et al., 1997). CRX is predominantly
expressed in retinal photoreceptor cells and controls12 Correspondence: laspada@u.washington.edu
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Figure 1. Production and Expression Analysis of SCA7 Transgenic Mice
(A) Ataxin-7 transgenic constructs. The ataxin-7 coding region carrying either a normal-length 24 CAG repeat or an expanded 92 CAG repeat
was subcloned into the XhoI site of the MoPrP expression vector to yield the transgenic constructs PrP-SCA7-c24Q and PrP-SCA7-c92Q.
The hatched boxes represent MoPrP exons with the 3 processing signals provided by the MoPrP gene sequences.
(B) RT-PCR analysis. RNA was isolated from brain tissue of mice (from different transgenic lines or a nontransgenic control, as indicated
above the lanes) and then subjected to RT-PCR. Primers that anneal to both the human (transgene) ataxin-7 and the mouse (endogenous)
ataxin-7 coding region yielded a 1322 bp human/mouse product, except for samples that lacked reverse transcriptase (indicated as RT).
Vector DNA served as a positive control for the PCR amplification step. The PCR products were digested with XmnI and yielded 414 bp, 420
bp, and 488 bp fragments in mice expressing the human transgene.
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the expression level of numerous photoreceptor-spe- HEK293T cells and detected full-length ataxin-7 on
Western blot analysis (Figure 1C).cific genes, including rhodopsin and the color opsins
(Chen et al., 1997; Furukawa et al., 1999). Mutations
in the CRX gene cause autosomal dominant cone-rod
Production and Characterizationdystrophy type II and Leber’s congenital amaurosis in
of Transgenic Micehumans (Freund et al., 1997, 1998; Swain et al., 1997),
After pronuclear injection into oocytes from B6C3 F1while CRX null mice show progressive retinal degenera-
hybrids, we identified five founders (one PrP-SCA7-tion, lose visual function, and display reductions in the
c24Q mouse and four PrP-SCA7-c92Q mice). We per-expression of CRX target genes (Furukawa et al., 1999).
formed Southern blot analysis and found that copy num-To test the hypothesis that polyglutamine-expanded
ber ranged from one to six in the various lines (data notataxin-7 interferes with CRX-dependent transcription,
shown). To establish relative expression levels of thewe performed yeast two-hybrid assays and found that
transgene in the different lines, we developed an RT-ataxin-7 and CRX interact. To confirm the ataxin-7-CRX
PCR strategy (Figure 1B). Using this approach, we deter-interaction and to assess its functional significance, we
mined the expression level of the ataxin-7 transgene incoimmunoprecipitated ataxin-7 with CRX and found that
each line (Table 1). We generated polyclonal antibodiesataxin-7 and CRX colocalize in nuclear aggregates. Us-
against human ataxin-7 by affinity purification of seraing a rhodopsin promoter-reporter construct, we ob-
obtained from rabbits that had been immunized withserved dramatic suppression of CRX transactivation by
ataxin-7 fused to GST or with oligopeptides. We usedpolyglutamine-expanded ataxin-7. Electrophoretic mo-
one of these antibodies, K, to probe Western blots andbility shift assay analysis of SCA7 transgenic retinas
found an 130 kDa band in the 92Q transgene-positiverevealed that CRX is deficient in its ability to bind to its
mice, confirming expression of full-length ataxin-7 atconsensus sequence. We then assessed the expression
the protein level (Figure 1C).levels of CRX-regulated genes in the retinas of SCA7
To determine the expression pattern of the ataxin-7transgenic mice and found significant reductions in CRX
transgene, we immunostained retinal sections with an-targets. These data suggest that our SCA7 transgenic
other ataxin-7 polyclonal antibody, A, and detectedmice faithfully recapitulate the process of retinal degen-
ataxin-7-92Q protein in the outer nuclear layer (ONL),eration observed in human SCA7 patients and that
the inner nuclear layer (INL), and the ganglion cell layerataxin-7-mediated transcription interference of photore-
(GCL) (Figure 1D). We observed punctate staining inceptor-specific genes may account for the cone-rod
all three nuclear layers, and we confirmed the nucleardystrophy phenotype in SCA7.
localization of ataxin-7 by stereoscopic imaging of the
punctate staining (Figure 1E). The areas of punctate
staining resemble the nuclear inclusions (NIs) reported inResults
other polyglutamine repeat diseases and mouse models
(Ross, 1997), indicating that ataxin-7 is aggregating intoTransgenic Constructs
To produce a mouse model of SCA7, we inserted the NIs in the retinas of the PrP-SCA7-c92Q mice. The NIs
could also be detected with the 1C2 and Hsc-70 antibod-ataxin-7 coding region into the murine prion protein pro-
moter (MoPrP) construct, as this vector has been shown ies (Figure 3C), and the number of NIs increased with
the age of the mice (data not shown). Review of theto drive high-level expression in all neurons, including
retina (Borchelt et al., 1996). We subcloned ataxin-7 Western blot analysis revealed immunostained material
that did not migrate out of the stacking portion of thecDNAs into the MoPrP vector to yield two transgenic con-
structs (Figure 1A): designated “PrP-SCA7-c24Q” and acrylamide gels (Figure 1C). This material likely corre-
sponds to aggregates of ataxin-7, and its appearance“PrP-SCA7-c92Q,” respectively. To confirm that these
constructs were capable of driving proper translation of correlates with increasing transgene expression level
and age.full-length ataxin-7, we transiently transfected them into
(C) Western blot analysis. Protein was isolated from transiently transfected HEK293T cells (2 g) or from mouse retinas (20 g) and then
immunoblotted with polyclonal antibody K sera at a dilution of 1:1000. The first three lanes on the left respectively correspond to HEK293T
cells transfected with empty vector (), PrP-SCA7-c24Q (24Q), and PrP-SCA7-c92Q (92Q). Ataxin-7 with 24 glutamines migrates at 115 kDa,
while ataxin-7 with 92 glutamines migrates at 130 kDa, and both are detected in transfected HEK293T cells. Note also that a faint band
migrating at 110 kDa is detected in the empty vector lane and likely represents endogenous expression of ataxin-7 with ten glutamines.
The five lanes on the right correspond to nuclear extracts of retina protein from various mice: two nontransgenics (nt), a PrP-SCA7-c24Q
transgenic mouse (24Q), and two PrP-SCA7-c92Q transgenic mice (92Q). The 92Q mouse on the left is a 14-week-old individual from line
6561, while the 92Q mouse on the right is a 7-week-old individual from line 6561. The PrP-SCA7-c24Q mouse shows an intense band at 115
kDa, while the 92Q mouse on the left shows a faint band at 130 kDa, and the 92Q mouse on the right shows an intense band at 130 kDa.
The bracket with the asterisk is pointing out immunostaining material at the top of the gel for both of the PrP-SCA7-c92Q transgenic mice.
This material likely corresponds to aggregates containing ataxin-7. Blots were reprobed with the p44/42 MAP kinase antibody to confirm
equivalent protein loading of the retinal samples.
(D) The ataxin-7 transgene is expressed in all three nuclear layers of the retina. Sections from a PrP-SCA7-c92Q mouse were immunostained
with antibody A (green) and counterstained with propidium iodide (red). The resulting confocal image reveals a nuclear expression pattern of
the ataxin-7 transgene with punctate staining apparent in the ONL, the INL, and especially the GCL (marked with arrows).
(E) Ataxin-7-92Q accumulates in the nucleus. Stereoscopic images generated from antibody A-immunostained retinal sections confirm that
ataxin-7 localizes to the nuclei of cells. The GCL is shown here. OS, outer segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
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Table 1. Summary of Expression and Phenotype Data for the PrP-SCA7 Transgenic Mice
Expression Levela (Rela- Age of Onset of Retinal
Transgenic Line tive to Endogenous) Pathologyb Age of Blindnessc
6076-92Q 1.75 11 weeks 13 weeks
6080-92Qd NDe ND ND
6129-24Q 2.0 normal at 47 weeks normal at 47 weeks
6529-92Q 0.75 normal at 46 weeks mildly impaired at 29 weeks
(not blind at 46 weeks)
6561-92Q 2.5 6 weeks 9 weeks
a RT-PCR analysis comparing the human transgene level to endogenous ataxin-7 was performed as described in the Experimental Procedures
section. All samples were run in triplicate, and the average of the three runs was rounded to the nearest 0.25.
b A mouse was considered to display retinal pathology if the outer nuclear layer of its retina showed areas of photoreceptor cell thinning to
less than ten nuclei across.
c Line 6080 produced two transgene-positive N2 progeny, both of which showed early onset of a neurological phenotype and failed to
successfully reproduce prior to their death.
e ND, not determined.
PrP-SCA7-c92Q Mice Show a Cone-Rod Dystrophy genic mice are clearly activated (Figure 3C). Mu¨ller cells,
which serve the function of astrocytes in the CNS, be-Type of Retinal Degeneration
To evaluate our transgenic mice for retinal abnormali- come activated when neurotransmission in the retina
is impaired and a process of injury or degeneration isties, we began by studying retinal cytoarchitecture (Ta-
ble 1). In 22-week-old nontransgenic littermate controls underway (Dyer and Cepko, 2000; Zack, 2000). We also
performed TUNEL staining and found that the retinasand PrP-SCA7-c24Q mice, the retinal ONL is of normal
thickness, measuring 12 nuclei across (Figure 2A). of PrP-SCA7-c92Q mice show an increased number of
TUNEL-positive photoreceptor cells (Figure 3D), sug-PrP-SCA7-c92Q mice, however, showed periodic thin-
ning of the ONL, with some regions narrowing to as few gesting that apoptosis may account for the ONL
thinning.as six nuclei across (Figure 2A). To exclude a develop-
mental defect, we obtained retinal sections from line To determine if the SCA7 transgenic mice are visually
impaired, two types of ERG studies were carried out on6076 mice at 7 weeks of age and found that the retinal
ONL of young adult PrP-SCA7-c92Q mice is of normal mice after dark adaptation. In one case, we recorded
the primary response of rod photoreceptor cells. In thethickness (Figure 2B). By 12 weeks of age, however, line
6076 mice begin to display patchy thinning of the ONL. other case, we saturated the rod photoreceptor cells
to eliminate their contribution and then recorded theThis patchy ONL thinning becomes more apparent at 16
weeks of age, until it progresses to prominent, periodic remaining response from cone photoreceptors. The
ERGs indicated that the PrP-SCA7-c92Q mice sufferscalloping of the ONL by 21 weeks of age (Figure 2B).
As the PrP-SCA7-c92Q mice are born with histologically loss of visual function (Table 1; Figure 4). Comparison
of the rod-initiated responses (top panels) with cone-normal retinas, such progressive thinning of the ONL is
consistent with photoreceptor cell degeneration. In the initiated responses (lower panels) revealed that cone-
driven responses are degraded faster than rod-drivenmost severely affected PrP-SCA7-c92Q transgenic mice
(i.e., line 6561), the ONL narrows to just four nuclei across, responses in the PrP-SCA7-c92Q mice (Figure 4). These
findings are consistent with our morphological observa-with collapse of the outer retina (Figure 2C). At this stage,
prominent NIs are visible in all three nuclear layers of tions that cone photoreceptors degenerate prior to rod
photoreceptors in the 92Q transgenic mice.the retina when immunostained with an anti-Hsc 70 anti-
body (Figure 2C). Funduscopic examinations performed
on such line 6561 92Q mice revealed numerous halo-like Interaction of Ataxin-7 and CRX: Yeast Two-Hybrid
Assays, Coimmunoprecipitation,areas of depigmentation distributed at regular intervals
throughout the entire retina (data not shown). and Colocalization in Nuclear Aggregates
As a first step to assess if ataxin-7 and CRX physicallyTo characterize the histopathology in the SCA7 trans-
genic mice, we examined retinal whole mounts for cone interact, we performed a Gal4-based yeast two-hybrid
assay using ataxin-7 as the “bait” and CRX as the “prey.”photoreceptor cells with antibody JH492 (directed
against green cone pigment; kind gift of J. Nathans). The bait and prey interaction was measured using the
HIS3, lacZ dual reporter assay. When Y190 yeast cellsAlthough nontransgenic mice exhibited significant num-
bers of cone photoreceptors, the PrP-SCA7-c92Q mice were cotransformed with ataxin-7 (10Q or 62Q) and CRX,
expression of the HIS3 and lacZ reporter genes wasshowed dramatic loss of cone photoreceptor cells from
comparable regions of the retina (Figure 3A). We con- activated (Figure 5A). Specificity of the interaction was
confirmed by the loss of reporter activation in trans-firmed this result by immunostaining retinal sections
(Figure 3B). These studies revealed that cone photore- formed cells harboring either an unrelated bait (pAS-
Snf1) or an empty prey vector (pACT2). Furthermore,ceptor cells are vastly underrepresented in the PrP-
SCA7-c92Q mice. We then immunostained the retinal when a prey construct containing another retinal tran-
scription factor, neural retina leucine zipper proteinsections with an antibody against glial fibrillary acidic
protein (GFAP). The anti-GFAP staining showed that (NRL), was cotransformed with the ataxin-7 bait con-
structs, activation of reporter gene expression was notMu¨ller cells in the retinas of the PrP-SCA7-c92Q trans-
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Figure 2. Retinal Histology of SCA7 Transgenic Mice
(A) Photoreceptor cell loss in PrP-SCA7-c92Q mice. Retinal sections from 22-week-old mice (NT, nontransgenic littermate control; 24Q, PrP-
SCA7-24Q line 6129; 92Q, PrP-SCA7-92Q line 6076) were stained with 10% Richardson’s solution. While the NT and 24Q retinas show normal
retinal cytoarchitecture, periodic thinning of the ONL (marked by arrows) is apparent in the PrP-SCA7-c92Q mouse. The inset highlights the
photoreceptor cell loss in the 92Q mice.
(B) Progressive, degenerative nature of the photoreceptor cell loss in PrP-SCA7-c92Q mice. Retinal sections from line 6076 mice at different
ages were stained with 10% Richardson’s solution. At 7 weeks, there is no obvious retinal histopathology. At 12 weeks, periodic thinning of
the ONL to 10 photoreceptor cell nuclei can be seen. At 16 weeks, the patchy areas of ONL thinning both widen and deepen. By 21 weeks,
there is marked periodic thinning of the ONL.
(C) Photoreceptor cell degeneration is accompanied by nuclear inclusion formation in the PrP-SCA7-c92Q mice. Paraffin-imbedded retinal
sections from 11-week-old mice (NT, nontransgenic littermate control; 24Q, PrP-SCA7-24Q line 6129; 92Q, PrP-SCA7-92Q line 6561) were
immunostained with an Hsc-70 antibody and then visualized with a secondary antibody conjugated to diaminobenzidine after antigen retrieval.
Note the profound thinning of the ONL and dislocation of photoreceptor cells into the segment layers in the 92Q mouse. Hsc-70 labeling
reveals areas of dense, punctate staining in the nuclei of cells in the ONL, INL, and GCL of the 92Q retina. The inset highlights the appearance
of these nuclear inclusions in the photoreceptor cell layer. OS, outer segments; IS, inner segments; ONL, outer nuclear layer; OPL, outer
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
observed, suggesting that the ataxin-7-CRX interaction tope tag. Although CRX can be immunoprecipitated with
ataxin-7 using the Myc antibody, NRL could not be im-is specific. To determine the nature of the ataxin-7-CRX
interaction, we performed in vitro coimmunoprecipita- munoprecipitated. These results suggest that polyglu-
tamine-expanded ataxin-7 can physically interact withtion assays. As shown in Figure 5B, ataxin-7 with either
10 or 92 glutamines can be immunoprecipitated by the CRX but not with NRL. As nuclear extracts of mouse
retinas yield a limited quantity of protein, in vivo coimmu-anti-CRX antibody only when the CRX protein is present.
To verify this result, we repeated the coimmunoprecipi- noprecipitation assays were precluded by the lack of a
sufficiently avid antibody (data not shown).tation but used an anti-myc antibody for the pull-down,
as the ataxin-7 expression vector contains a Myc epi- To assess the ataxin-7-CRX interaction in mammalian
Neuron
918
Figure 3. Loss of Cone Photoreceptor Cells
in the PrP-SCA7-c92Q Mice
(A) Whole mounts of the retina were prepared
from a PrP-SCA7-c92Q mouse (92Q, line
6076, age 13 weeks) and its nontransgenic
littermate control (NT). Although antibody
JH492 (against green cone pigment) labels
numerous cone cells in the midperiphery of
the nontransgenic retina, only a small fraction
of cone cells are labeled in the same region
of the 92Q retina. This difference in cone cell
number between the 92Q and the NT control
was observed in the central and far-periph-
eral regions of the retina as well (data not
shown). The large areas of dark-staining ma-
terial correspond to residual attached pieces
of the RPE.
(B) Antibody JH492 (green) labels the outer
segments of numerous cone cells in NT con-
trol retina, while outer segments from only
two cone cells (marked by arrows) can be
seen in the 92Q retina. This profound differ-
ence in cone cell numbers was also seen
when we immunostained with antibody
JH455 against the blue cone pigment (data
not shown). Nuclei are counterstained red by
propidium iodide. Note that patchy thinning
is not observed in the 92Q confocal image
because of superimposition of adjacent nu-
clei in the z plane.
(C) GFAP immunostaining (green) and propid-
ium iodide counterstaining (red) of the 92Q
retina reveals activated Mu¨ller cell processes
extending from the GCL through the IPL and
the INL into the OPL and ONL. NT littermate
control retina in contrast lacks Mu¨ller cell
gliosis.
(D) TUNEL staining reveals TUNEL-positive
photoreceptor cells (marked by arrows) in the
ONL of the 92Q retina, but no TUNEL-positive
photoreceptor nuclei are seen in the NT con-
trol. OS, outer segments; IS, inner segments;
ONL, outer nuclear layer; OPL, outer plexi-
form layer; INL, inner nuclear layer; IPL, inner
plexiform layer; GCL, ganglion cell layer; RPE,
retinal pigmented epithelium.
cells, we coexpressed ataxin-7-10Q or ataxin-7-69Q CRX antibody epitope is masked during the process of
fixation or sequestered in the interior of the nuclearfused to green fluorescent protein (GFP) with Xpress
epitope-tagged CRX in HEK293T cells. Ataxin-7 and inclusion.
CRX both localized to the nuclei of HEK293T cells (Fig-
ures 6A–6C). Ataxin-7-10Q-GFP yielded diffuse nuclear Polyglutamine-Expanded Ataxin-7 Interferes
with CRX Transactivationstaining, as did CRX, and they showed colocalization in
HEK293T cells (Figures 6D–6F). Expression of polyglu- Since mutations in the photoreceptor transcription fac-
tor CRX cause the cone-rod dystrophy phenotypetamine-expanded ataxin-7, however, led to the produc-
tion of nuclear aggregates with little residual nuclear (Freund et al., 1997, 1998; Swain et al., 1997), we hypoth-
esized that polyglutamine-expanded ataxin-7 may inter-staining (Figure 6G). CRX also localized to the nuclear
aggregates (Figure 6H), showing nearly complete colo- fere with CRX transcription regulation of photoreceptor
genes. Previous studies have shown that the rhodopsincalization with ataxin-7-69Q-GFP when the images were
merged (Figure 6I). After observing coimmunoprecipita- promoter region 225 to 70 is important for directing
photoreceptor-specific rhodopsin expression, as it con-tion and colocalization, we immunostained retinal sec-
tions from the SCA7 transgenic mice with the CRX anti- tains binding sites for CRX and NRL (Chen et al., 1997;
Rehemtulla et al., 1996). Transient cotransfection assaysbody. Although we noted much denser and more
particulate staining in the photoreceptor nuclei of PrP- in HEK293T cells have demonstrated that CRX can
transactivate a rhodopsin promoter-reporter constructSCA7-c92Q mice, CRX immunostaining did not reveal
obvious NIs (data not shown). Immunostaining with an and that this transactivation activity is greatly enhanced
by coexpression of NRL (Chen et al., 1997). We thusanti-CREB binding protein (CBP) antibody did detect
discrete NIs in all three nuclear layers (data not shown). decided to test the effect of ataxin-7 overexpression on
the transactivation capacity of CRX alone, NRL alone,Lack of CRX detection in retinal NIs may mean that the
SCA7 Mouse Model Shows Impairment of CRX Function
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Figure 4. ERG Analysis of Transgenic Mice
Representative rod-initiated and cone-initiated responses for a nontransgenic normal control and three transgenic mice at different stages
of retinal degeneration are shown. Each ERG was performed at a range of light intensities, and the position of the tracings corresponds to
the light intensity employed from dimmest (bottom) to brightest (top) along the ordinate. To allow comparison of the light intensities, a scale
bar corresponding to 200V is given. Mildly affected transgenic mice show a reduction in the cone response while maintaining normal rod
responses. Further reduction in cone response is seen in moderately affected transgenic mice with only a slight reduction in the rod response.
Transgenic mice ultimately become severely affected and go blind, as indicated by an absence of both the cone and rod responses to the
brightest light flash. Mild ERG changes were observed in 4-week-old line 6561 mice, 7-week-old line 6076 mice, and 29-week-old line 6529
mice (shown here). Moderate ERG abnormalities were seen in 7-week-old line 6561 mice (shown here) and 10-week-old line 6076 mice.
Absence of the ERG response was noted in 9-week-old line 6561 mice and 13-week-old line 6076 mice (shown here).
and CRX NRL using this assay. Consistent with previ- transactivation (p  0.09–0.90), suggesting that the ef-
fect on photoreceptor gene transcription is specific toous observations, HEK293T cells cotransfected with
pBR225-luc and either a CRX or NRL expression vector polyglutamine-expanded ataxin-7. To further assure
that ataxin-7 transcription interference is not a generalexhibited a 3- to 6-fold increase in rhodopsin promoter
activity, while concomitant expression of CRX and NRL effect, we tested the ability of pSCA7-69Q-EGFP (100
ng) to repress Gal4-VP16 activation of a Gal4-luc re-yielded a 40- to 50-fold increase (data not shown). Co-
transfection of HEK293T cells with pSCA7-69Q-EGFP porter and observed no suppression (data not shown).
The marked transcription interference in the rhodop-substantially suppressed CRX- and NRL-mediated tran-
scription activation in a concentration-dependent man- sin promoter-reporter assays led us to investigate
whether CRX-regulated gene expression is impaired inner (p  0.005), with roughly 40% of full activation de-
tected at a low concentration and only 20% of full the PrP-SCA7-c92Q mice. We began by performing
Western blot analysis of CRX and found that CRX proteinactivation detected at a higher concentration (Figure
7A). Although a low concentration of the pSCA7-10Q- levels are reduced in 14-week-old 92Q transgenic mice
who have suffered significant loss of photoreceptor cellsEGFP expression did not suppress the transactivation
(p  0.16–0.64), cotransfection of pSCA7-10Q-EGFP at (Figure 7B). In visually impaired 7-week-old 92Q mice
with less advanced retinal disease, however, CRX pro-a higher concentration did inhibit the transactivation
activity (p  0.01). Suppression of the rhodopsin pro- tein levels are not reduced, suggesting that a decrease
in CRX does not precede onset of the retinal phenotype.moter-reporter construct by ataxin-7-10Q at an elevated
expression level is consistent with studies of SCA1 We then isolated nuclear extracts from the retinas of
6-week-old presymptomatic ataxin-7-92Q mice as wellmouse and fly models that show a deleterious effect
of wild-type ataxin-1 when overexpressed (Fernandez- as from a group of controls. Electrophoretic mobility
shift assays performed on these nuclear extracts indi-Funez et al., 2000). To confirm the specificity of ataxin-7
photoreceptor transcription interference, we cotrans- cated that 92Q mice destined to suffer retinal degenera-
tion show significantly less binding of CRX to Ret-4, afected HEK293T cells with CRX, NRL, CRX  NRL, and
an androgen receptor (AR) expression construct that CRX-responsive element in the rhodopsin promoter, than
nontransgenic, 24Q, and low-expressing 92Q controlsencodes the full-length AR with 74 glutamines (pAR-
74Q-EGFP). As shown in Figure 7A, cotransfection of (Figure 7C). Impaired CRX binding of the consensus
CRX regulatory sequence in line 6076 92Q retinas sug-pAR-74Q-EGFP at a high concentration (100 ng) did
not result in significant suppression of CRX-dependent gested a potential effect on the expression levels of
Neuron
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Figure 5. Ataxin-7 and CRX Directly Interact
but Ataxin-7 and NRL Do Not
(A) Yeast two-hybrid assay demonstrates the
ataxin-7-CRX interaction. Various combina-
tions of bait and prey constructs were cotran-
sformed into yeast Y190 cells and then tested
for reporter activity as shown (see Table 1),
with the known interacting partners Snf1 and
Snf4 serving as the positive control. In the
absence of 3-AT, growth is observed for all
cotransformants, as there is leaky expression
from the HIS3 reporter. However, when grown
in media containing 60 mM 3-AT, only those
cotransformants whose protein products in-
teract to activate expression from the HIS3
reporter gene survive, identifying ataxin-7
10Q CRX, ataxin-7 62Q CRX, and Snf1
Snf4 as pairs of interacting proteins. In the
-gal test, filter lifts of the yeast cotransfor-
mants were exposed to X-gal, a chromogenic
substrate which upon cleavage by -galac-
tosidase yields a blue color. Expression of
-galactosidase from the lacZ reporter gene
is observed for pairs of interacting proteins,
identifying ataxin-7 10Q  CRX, ataxin-7
62Q  CRX, and Snf1  Snf4 once again.
(B) Ataxin-7 and CRX coimmunoprecipitation
with a CRX-specific antibody. After subclon-
ing ataxin-7 with 10 or 92 glutamines into a
Myc-tag expression vector (pMT), S35-labeled
pMT protein products were generated by in
vitro transcription-translation. The CRX cod-
ing region was similarly subcloned into a
poly-His expression vector (pcDNA3.1/HisC),
and unlabeled pCDNA3.1/HisC protein prod-
ucts were generated. Lanes 1 through 3 are
input controls that show in vitro transcribed-
translated products of the pMT constructs,
while lanes 4 through 8 are combinations of
in vitro transcribed-translated pMT and
pcDNA3.1/HisC constructs that were immu-
noprecipitated with the anti-CRX antibody
p261. The presence of ataxin-7-92Q and
ataxin-7-10Q in lanes 5 and 7, respectively,
indicate that the CRX antibody was able to
immunoprecipitate these proteins, indicating
a physical interaction between ataxin-7 and
CRX.
(C) Coimmunoprecipitation of CRX but not
NRL with ataxin-7. S35-labeled CRX and NRL
were generated from their respective
pcDNA3.1/HisC vectors and combined with
unlabeled Myc-tag ataxin-7-92Q or Myc-tag
product alone. Lanes 1 through 4 show the
indicated combination of proteins, while
lanes 5 and 6 are input controls. CRX coim-
munoprecipitates with ataxin-7 (lane 4), while
NRL and ataxin-7 do not coimmunoprecipi-
tate (lane 1).
CRX-regulated genes. To test this hypothesis, we iso- ized to the level of 18S RNA to insure that any alterations
would be specific (Gibson et al., 1996). We detectedlated total RNA from the retinas of presymptomatic 92Q
juvenile mice (postnatal day 28) and from age-matched significant reductions in the message levels of all four
CRX targets in the line 6076 92Q mice but observed nolittermate and 24Q controls. We then performed real-
time RT-PCR assays and measured the expression levels significant change in the expression level of the non-
CRX target (Figure 7D). Reduction in the cone-expressedof blue cone opsin (BCP), cone arrestin (CARR), rod--
transducin (GNAT1), and rhodopsin (RHO): four photore- genes (i.e., BCP and CARR) was particularly marked,
being significantly greater than the reductions in the rod-ceptor genes regulated by CRX. We also measured the
expression level of rhodopsin kinase (RHOK), a photore- expressed genes (RHO and GNAT1) (p 0.05). Northern
blot analysis and competitive RT-PCR assays indepen-ceptor-specific gene that is not subject to CRX regula-
tion. All expression-level measurements were normal- dently confirmed the reductions in the message levels
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tion. In SCA7 patients, the thickness of the ONL is uni-
formly reduced by more than 25% throughout the central
retina (To et al., 1993). The PrP-SCA7-c92Q mice show
a similar degree of photoreceptor cell loss, but, unlike
in the human, ONL thinning in our transgenic mice is
patchy. In the human, cone cells are grouped together
in the central retina and form the fovea. The periodic
nature of ONL thinning in the PrP-SCA7-c92Q mice likely
reflects the fact that rodents lack a fovea, and their cone
cells are widely dispersed. Whole mounts of the retina
and immunostaining with pigment-specific antibodies
illustrated that this periodic ONL thinning was due to a
preferential loss of cone photoreceptor cells in the reti-
nas of the SCA7 transgenic mice.
Although the PrP-SCA7-c92Q mice suffer loss of pho-
toreceptor cells and distortion of the retinal cytoarchi-
tecture in the most severely affected individuals, ERG
abnormalities develop when only subtle changes in reti-
Figure 6. Colocalization of Ataxin-7 and CRX in HEK293T Cells nal histology are apparent. At 7 weeks of age, the PrP-
HEK293T cells were cotransfected with pcDNA3.1/His-CRX and ei- SCA7-c92Q mice from line 6076 do not display ONL cell
ther pSCA7-10Q-GFP or pSCA7-69Q-GFP. Subcellular localization loss and have normal-appearing retinas, indicating that
was determined by GFP fluorescence (B, D, F, G, and I) and by their phenotype is not developmental in nature. Rather,immunostaining with the anti-Xpress antibody (C, E, F, H, and I).
the retinas of mice from this line show progressive(A–C) Cells were stained with Hoechst 33342 dye to detect nucleic
changes and loss of photoreceptor cells, consistent withacid. Deconvoluted fluorescent images reveal nuclear staining of
untransfected HEK293T cells (A) and indicate that both ataxin-7- a degenerative process. The amount of overall photore-
69Q (B) and CRX (C) localize to the nucleus. (D–F) Cotransfection ceptor cell elimination, however, cannot account for the
of ataxin-7-10Q and CRX reveals nuclear colocalization. Ataxin-7- rapid and total loss of visual function, as ERG analysis
10Q (D) and CRX (E) show diffuse nuclear staining, while the merged indicates that SCA7 transgenic mice are completely
image reveals colocalization within the nuclear compartment of the
blind with only minimal histopathology. Given this obser-visualized cell (F). (G–I) Cotransfection of ataxin-7-69Q and CRX
vation, it appears that photoreceptor cell dysfunctionresults in colocalization in nuclear aggregates. Expression of ataxin-
rather than cell death is the cause of their blindness.7-69Q (G) leads to nuclear aggregate formation. CRX (H) localizes
to the nuclear aggregates. Colocalization of ataxin-7-69Q and CRX If the PrP-SCA7-c92Q mice accurately model ataxin-7
in nuclear aggregates (I) is confirmed on the merged image. retinal degeneration and photoreceptor transcription in-
terference is the primary problem, then restoration of
proper transcription factor function in diseased photore-of CRX-regulated genes in the presymptomatic SCA7
ceptor cells may prevent blindness in SCA7.
transgenic mice (data not shown).
Although entry of a polyglutamine-expanded protein
or peptide into the nucleus is not required to produce
Discussion
cellular dysfunction in all polyglutamine repeat diseases
(Huynh et al., 2000), studies of HD and SCA1 suggest
We have generated a mouse model of SCA7 by express- that nuclear entry is a necessary step for pathogenesis
ing a human ataxin-7 transgene with 92 glutamines in to proceed in these two disorders (Klement et al., 1998;
the central nervous system and retina. PrP-SCA7-c92Q Saudou et al., 1998). In the PrP-SCA7-c92Q mouse
mice and their transgenic control 24Q counterparts both model, we observed intense nuclear staining and aggre-
show expression at the RNA and protein level. The PrP- gate formation in all three nuclear layers of the retina.
SCA7-c92Q mice develop a cone-rod dystrophy type of Our results showing NI formation are consistent with
retinal degeneration and lose visual function. Expression studies of SCA7 patients and with another transgenic
of the ataxin-7 transgene throughout all three nuclear mouse model of SCA7 (Holmberg et al., 1998; Mauger et
layers of the retina parallels the expression of ataxin-7 al., 1999; Yvert et al., 2000). Except for the polyglutamine
in human retina (Lindenberg et al., 2000) and likely ac- tract, the gene products that cause the CAG repeat
counts for accurate recapitulation of the SCA7 cone-rod diseases do not display any shared amino acid homol-
dystrophy phenotype. When expression of polyglutamine- ogy or functional domains. One hypothesis for polyglu-
expanded ataxin-7 is restricted to rod photoreceptors tamine neurotoxicity posits aberrant interaction with
as in a previous study, mice do not develop a cone-rod other proteins containing polyglutamine stretches. As
dystrophy nor do they lose full visual function (Yvert et many nuclear transcription factors possess polygluta-
al., 2000). In addition to the retinal phenotype, the PrP- mine tracts, nuclear localization of mutant polygluta-
SCA7-c92Q mice show a complex neurological pheno- mine peptides suggests that expanded polyglutamine
type consisting of gait ataxia and an involuntary move- tracts may bind to and interfere with transcription fac-
ment disorder (A.R.L. et al., unpublished data). The age tors and coactivators (Ferrigno and Silver, 2000; Paulson
of onset and severity of the phenotype reflect the level of et al., 2000). Indeed, at least three studies have reported
expression of the ataxin-7 transgene in four independent that polyglutamine expansions can inhibit CREB-depen-
lines of PrP-SCA7-c92Q mice. dent transcription by disrupting the function of coactiva-
SCA7 is unique among the SCAs because its clinical tors such as CBP or a TATA binding protein-associated
factor (McCampbell et al., 2000; Shimohata et al., 2000;presentation includes a novel form of retinal degenera-
Figure 7. Ataxin-7 Transcription Interference
(A) Polyglutamine-expanded ataxin-7 interferes with CRX transactivation. HEK293T cells were transiently transfected with 2.0 g of pBR225-
luc, 100 ng of a CRX expression vector (solid black), 100 ng of a NRL expression vector (hatched pattern), or 100 ng each of the CRX and
NRL expression vectors together (horizontal lines). In the first set of transfections, nothing else was cotransfected (“None”), but, in subsequent
experiments, the vectors shown along the abscissa were added at the amounts indicated. Luciferase activity was normalized to pRL-CMV,
an internal control included in the cotransfection, and the relative luciferase activity was determined in comparison to cells cotransfected
with pBR225-luc, pRL-CMV, and the transcription factor(s) indicated by the shading of the bars. Results are mean 	 SD (n  3).
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Nucifora et al., 2001). Although this is an attractive To determine if the CRX transactivation suppression
observed in HEK293T cells could be corroborated inmodel, it does not address how each polyglutamine
repeat disease shows a particular pattern of neuropa- vivo, we performed electrophoretic mobility shift assays
on transgenic and control retinas. Nuclear extracts ob-thology despite overlapping expression of the different
disease genes. tained from 92Q retinas destined to degenerate dis-
played marked reductions in the ability of CRX proteinTo explain how polyglutamine-expanded ataxin-7
causes cone-rod dystrophy, we reasoned that ataxin-7 to bind to its target DNA consensus binding site, sup-
porting the CRX transcription interference model. Tomay inappropriately interact with CRX once the polyglu-
tamine tract expands into the mutant size range. Consis- confirm that polyglutamine-expanded ataxin-7 was in-
terfering with CRX transactivation in vivo, we determinedtent with this hypothesis, we found that ataxin-7 and
CRX interact in a dual reporter yeast two-hybrid assay the mRNA expression levels of four CRX target genes
and one CRX nontarget gene in presymptomatic mice.and that a CRX antibody coimmunoprecipitates polyglu-
tamine-expanded ataxin-7 only in the presence of CRX. Using the TaqMan approach (Livak et al., 1995), we
found significant reductions in the message levels of allFurthermore, we observed that CRX and polyglutamine-
expanded ataxin-7 colocalize in nuclear aggregates four CRX target genes. Greater reduction of the cone-
expressed genes ahead of the rod-expressed genes waswhen coexpressed in HEK293T cells. CRX is a homeo-
domain protein that binds to a six-nucleotide consensus observed and is consistent with the cone-rod dystrophy
pathology in the SCA7 mice. Since the expression levelsequence in the promoters of various photoreceptor
cell-specific genes to drive their expression (Chen et al., of a photoreceptor-specific but non-CRX target gene
did not decrease in the 92Q transgenic retinas, the re-1997). For a subset of these genes—all expressed in
rods—CRX acts synergistically with NRL (Mitton et al., duction in the CRX targets appears to be specific and
not simply the by-product of a generally diseased retina.2000). Using a rhodopsin promoter-reporter construct,
we found that polyglutamine-expanded ataxin-7 can As the CRX mutations that cause cone-rod dystrophy
indicate (Freund et al., 1997; Furukawa et al., 1999),strongly suppress CRX and NRL transactivation, when
these factors are expressed alone or in combination. simultaneous reduction of multiple target genes in pho-
toreceptors can account for the retinal degenerationAlthough suppression of CRX transcription appears to
involve a direct interaction with ataxin-7, suppression observed in the SCA7 transgenic mice.
The polyglutamine repeat diseases are caused by aof NRL transcription by ataxin-7 is likely indirect, as CRX
and ataxin-7 coimmunoprecipitate but NRL and ataxin-7 variety of gene products that may share only one thing
in common—a tract of glutamines that expand to causedo not. Indirect suppression of NRL transcription may
involve CBP, as NRL transactivation assays indicate that neurodegeneration and disease. Much evidence has
been generated to support the hypothesis that the po-CBP is a coactivator of this AP-1-type factor (data not
shown). As NRL function is restricted to rods, the devel- lyglutamine tract expansion is neurotoxic, but a key
question remains unanswered—why do certain neuronsopment of a cone-rod dystrophy phenotype in our SCA7
transgenic model suggests that any effect upon NRL degenerate while other neurons that express the mutant
protein remain unaffected? Our study suggests that cell-in these mice would be minimal in comparison to the
transcription interference of CRX. type specificity in SCA7 retinal disease may stem from
(B) Western blot analysis of CRX. Protein (20 g) isolated from individual sets of mouse retinas were immunoblotted with anti-CRX antibody
p261 at a 1:250 dilution. Note that these are the same five mouse samples shown in Figure 1C. An intense band migrating at 39 kDa is seen
in all five samples. The band for the severely affected 92Q mouse on the left is reduced in intensity by roughly one-third according to
densitometric comparison, whereas the other four bands (including the sample from the 7-week-old visually impaired 92Q mouse [far right])
are of roughly equivalent intensity. The blot was reprobed with the p44/42 MAP kinase antibody to confirm equivalent protein loading of the
samples.
(C) Electrophoretic mobility shift assays reveal reduced CRX binding to its target site in 92Q retinas destined to degenerate. The Ret-4
regulatory element from the bovine rhodopsin promoter was used as a probe, as this DNA sequence is known to be recognized by CRX and
an unidentified ubiquitously expressed protein (Chen and Zack, 1996). Mouse retinal nuclear extract (1 l) was combined with 0.1 g of poly
dI-dC (Pharmacia), except for lane 11, while 1 l of the anti-CRX antibody p261 was also added to certain samples (as indicated). Although
all bands corresponding to the ubiquitously expressed protein (U) are of similar intensity, the intensity of the CRX-bound bands are markedly
less in nuclear retinal extracts from T657 and T557, two 6-week-old line 6076 mice, when compared to the CRX-bound bands in the
nontransgenic mouse (nt), low-expressing line 6529 92Q mouse (T766), and the 24Q mouse (T427). Decreased intensity of the CRX-bound
bands together with a supershift in the presence of the CRX antibody confirms the identify of the CRX-bound bands.
(D) Real-time RT-PCR analysis of blue cone opsin (BCP), cone arrestin (CARR), rod--transducin (GNAT1), rhodopsin (RHO), and rhodopsin
kinase (RHOK). Total RNAs from three sets of retina per mouse line (nt, nontransgenic littermate; 24Q, line 6129 PrP-SCA7-c24Q; 92Q, line
6076 PrP-SCA7-c92Q) were isolated from postnatal day 28 mice and reverse transcribed. Amplification plots representing the mean result
for each sample set are shown (nt, red; 24Q, green; 92Q, violet), with change in fluorescence (
Rn) plotted on the ordinate and cycle number
plotted on the abscissa. Thresholds (indicated as a solid horizontal black line) for each amplification are assigned during the exponential
phase of the amplification, allowing the determination of cycle thresholds (Ct). The 92Q amplification plots for BCP, CARR, GNAT1, and RHO
all require a greater number of cycles to reach the threshold in comparison to the controls, indicating decreased levels of these targets.
Amplification plots for RHOK show nearly identical Cts, indicating similar levels of this target. The bar graph on the right shows the RNA
expression level for the corresponding gene product for each set of transgenic mice as a percentage of the nt sample, after normalization to
18S RNA levels. The 92Q expression levels for BCP, CARR, GNAT1, RHO, and RHOK are, respectively, 54%, 73%, 83%, 93%, and 105% of
the nt, while the 24Q expression levels are, respectively, 89%, 91%, 96%, 104%, and 107%. Student’s t test comparison of the 92Q amplification
results to the 24Q results and to the nt amplification indicates significant reductions in the expression levels of BCP (p  0.0001), CARR (p 
0.001), GNAT1 (p  0.001), and RHO (p  0.05), but no significant difference in the level of RHOK (p  0.28 versus nt, p  0.35 versus 24Q).
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members of the otd/Otx family. Sera were obtained from rabbitstranscription interference. The primacy of transcription
immunized with this peptide (Quality Controlled Biochemicals), andinterference in HD and SCA1 is supported by the obser-
anti-CRX antibody p261 was affinity purified using the same peptide.vation that gene expression alterations are among the
Western blot analysis and super-shift gel mobility assays confirmed
earliest changes detected in mouse models of these two the specificity of the p261 anti-CRX antibody.
disorders (Lin et al., 2000; Luthi-Carter et al., 2000). For
polyglutamine repeat diseases characterized by nuclear Western Blot Analysis
Protein lysates were obtained by homogenizing tissues or cell pel-aggregates, transcription interference may be a princi-
lets in sample buffer (62.5 mM Tris-HCl [pH 6.8], 4% SDS, 200 mMpal event in disease pathogenesis, with the involved
dithiothreitol, 10% glycerol, 0.001% Bromophenol blue) at a ratiotranscription factors differing according to cell type.
of 1:10 (w/v) and then boiling. We generated nuclear extracts using
the NE-PER Nuclear and Cytoplasmic Extraction Reagents kitExperimental Procedures
(Pierce). Protein samples were resolved by 8% SDS-PAGE, trans-
ferred to nitrocellulose, and probed with antibody K or p44/42 MAPTransgenic Constructs
kinase antibody (New England Biolabs) at 1:1000 dilution in TBSThe full-length wild-type human SCA7 cDNA containing ten CAG
containing 0.1% Tween 20 and 5% BSA, after membrane blockingrepeats was isolated by screening a brain cDNA library (Stratagene)
in TBS with 0.1% Tween 20 and 5% nonfat dry milk. The primaryand assembled by RT-PCR using a Marathon cDNA brain library
antibody dilution for anti-CRX antibody p261 was 1:250. The primary(Clontech). The ataxin-7 coding region was PCR subcloned into the
antibody was visualized with horseradish peroxidase-coupled anti-EcoRI-SmaI sites of pGEX-5X-3 (Pharmacia) and pBluescript KS
rabbit antibodies (Amersham) at 1:2000 dilution and enhanced(Stratagene) as two fragments: a 711 bp EcoRI-PstI fragment and
chemiluminescence (Amersham).an2 kb PstI-SmaI fragment. We PCR amplified genomic DNA from
a SCA7 patient, using an EcoRI-tailed 5 primer and substituted a
Histology and Immunohistochemistry457 bp EcoRI-NarI fragment containing 92 CAGs into pBluescript
Mice under deep anesthetization were perfused transcardially withKS-SCA7-10Q. Using an oligonucleotide linker-adaptor protocol
4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). For(Moore, 1987), we placed SalI sites onto the ends of 2.7 or 2.9 kb
retinal histology, anterior chambers were removed and infiltratedEcoRI-SpeI fragments. SalI partial digests of these fragments were
with JB-4 methacrylate after washing and dehydration. Sections (5ligated into the XhoI cloning site of MoPrP to yield PrP-SCA7-c24Q
m thick) were cut and immersed in 10% Richardson’s stain. Forand PrP-SCA7-c92Q. An expansion of 14 CAGs occurred during the
whole mounts, dissected retinas were pretreated in metha-PrP-SCA7-c24Q cloning process. All reading frames were verified
nol:DMSO:30% H2O2 at a 4:1:1 ratio. Retinas were rehydrated inby PCR sequencing using the Big-Dye kit (ABI).
50% methanol, 20% methanol, and then PBS. For retinal sections,
fixed eyes were mounted in OCT compound and frozen prior toProduction and Characterization of Transgenic Mice
cutting 12 m thick sections on a cryostat. IHC was performed afterTranslational competence of the transgenic constructs was verified
blocking in 2% horse serum, 1% BSA, and 0.1% Triton X-100 inby transient transfection into HEK293T cells using Lipofectamine
PBS, and the primary antibody was diluted in 0.3% Triton X-100 in2000 (GIBCO-BRL). The vector backbone was removed by NotI di-
PBS. The antibodies used and their respective dilutions are as fol-gestion and then microinjected into oocyte pronuclei from C57BL/
lows: antibody A, 1:300; 1C2, 1:1000 (Chemicon); CBP, 1:200 (Santa6J  C3H/HeJ F1 hybrids. Founder mice were identified by PCR
Cruz); Hsc-70, 1:200 (StressGen); GFAP, 1:400 (Dako); JH455,analysis of tail DNAs using primers that flank the SCA7 CAG repeat:
1:5000; and JH492, 1:5000. Primary antibody staining was visualizedBS (5-TCGGAGCGGGCCGCGGATGAC-3) 4U-716 (5-CACGACTGT
with secondary antibody conjugated to different fluorochromes orCCCAGCATCACTT-3). Positive founders were backcrossed onto
with the ABC Vector elite kit (Vector labs) enhanced with diamino-the C57BL/6J strain background, as these mice do not carry the
benzidine. TUNEL labeling was performed with TUNEL label mixmutation for retinal degeneration (rd) (Pittler and Baehr, 1991). For
(Roche).Southern blot determination of copy number, 5 g of DNA was
digested with MscI and BamHI, resolved on 0.8% agarose gels,
Electroretinogramstransferred, and probed in Church and Gilbert hybridization solution
ERGs were recorded from anaesthetized mice using a gold wire/with a 1827 bp PmeI-NdeI fragment from the MoPrP vector (Church
contact lens electrode placed on the cornea. The reference elec-and Gilbert, 1984). Copy number was determined by densitometric
trode was placed in the mouth. Light flashes were delivered throughcomparison to DNA standards. To determine relative expression
a bifurcated fiber optic bundle using a lens to focus the light on thelevels, total RNA (1 g) from brain was reverse transcribed (using
cornea. Mouse rod ERG responses were recorded using flashesrandom hexamers) and the resulting cDNAs amplified in a total
estimated to cause certain numbers of photoisomerisations per rod:volume of 20 l with 1.5 Ci of dCTP-(-33P) (3000 Ci/mM; NEN)
0.03, 3, 30, 220, 2200, 2600, 4800, 15,000, 62,000, and 196,000.per reaction, using primers that anneal to both the human (trans-
Mouse cone 450 nm ERG responses were recorded using a pairedgene) ataxin-7 and mouse (endogenous) ataxin-7 coding region:
flash protocol (Lyubarsky et al., 1999). A bright conditioning flash(5-GGAAAAACCGCGAAGTCATGGGGCTCTG-3 and 5-CCATAGC
of white light (100 ms at 1 mW white light at the cornea) was firstTGTGCATTCAGATGCTTCTC-3). We then digested this 1322 bp
used to saturate rod photoreceptors for several seconds. Sinceproduct with XmnI and compared product intensities on a Phosphor-
cones recover more quickly than rods, cone b wave responses wereImager (Molecular Dynamics).
recorded 1.5 s after the conditioning flash using 450 nm stimuli. The
flash intensities at the cornea were 1.5 1020, 2.1 1019, 3.0  1018,Antibody Production
2.0  1017, and 4.1  1016 photons/cm2 at 450 nm.We synthesized an oligopeptide corresponding to amino acids 4 to
13 of ataxin-7 and conjugated it to keyhole limpet hemocyanin prior
to injection into New Zealand White rabbits. We also expressed Yeast Two-Hybrid Assays
Ataxin-7 coding regions containing either 10 or 62 glutamines wereglutathione S-transferase (GST)-ataxin-7-10Q fusion protein from
pGEX-5X-3 ataxin-7 and purified it using glutathione Sepharose fused in-frame with the Gal4 DNA binding domain in the pAS2 “bait”
vector, while the coding regions of either CRX or NRL were fusedresin (Furukawa et al., 1996). The affinity-purified GST-ataxin-7 pro-
tein was subjected to preparative SDS-PAGE, and a gel slice con- in-frame with the Gal4 activation domain in the pACT2 “prey” vector
(Matchmaker Two-Hybrid system, Clontech). Bait and prey plasmidstaining the recombinant fusion protein was injected into two New
Zealand White rabbits (Sopher et al., 1992). Affinity-purified sera were then cotransformed into yeast strain Y190 (MATa, ura3-5, his3-
200, ade2-101, lys2-801, trp1-901, leu2-3, 112, gal4
, gal80
, cyhr2,from rabbit A (oligopeptide immunization) and crude serum from
rabbit K (GST-ataxin-7 immunization) were then used for Western LYS2::GAL1UAS-HIS3TATA-HIS3, URA3::GAL1UAS-GAL1TATA-lacZ) and
analyzed for protein interactions using dual reporter assays. Forblot analysis and IHC. For polyclonal CRX antibody production, we
synthesized an oligopeptide spanning amino acids 261 to 274, as His3 expression, a 3-AT test was performed by spotting cell suspen-
sions on SD-Trp, Leu, His medium supplemented with or withoutthis peptide sequence does not share homology with any known
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60 mM of 3-amino-1,2,4-triazole (3-AT, a competitive inhibitor of according to the manufacturer’s instructions. Relative expression
levels of various transcripts were determined as previously de-His3p) and culturing for 4 days. For lacZ expression, a -galactosi-
dase test was performed using a colony-lift X-gal filter assay on scribed, with calibration curves generated for each transcript using
a serial dilution of nontransgenic retinal cDNA (Gibson et al., 1996).colony patches grown on SD-Trp, Leu, His plates containing 15
mM 3-AT. The yeast transformants that showed growth on the 60 Linear relationships (r  0.90) between the amount of sample and
cycle threshold (ct) values were obtained for all standard curves.mM-3AT medium and appeared blue on the X-gal filter were scored
as positive interactions. All cotransformations were performed in Relative abundances were determined by comparing the ct values
for each reaction with the standard curve and then normalizing totriplicate, and four to eight colonies per cotransformation plate were
tested in these assays. Transformants containing the known inter- the amount of 18S cDNA. Statistical comparisons were performed
using the Student’s t test.acting proteins Snf1 (in pAS1) and Snf4 (in pACT) were obtained
from S. Elledge and were included in each assay as a positive
control. Competitive RT-PCR Analysis
Primer sets (available upon request) corresponding to adjacent ex-
Coimmunoprecipitation ons of BCP, RHO, and glucose phosphate isomerase (the negative
S35-labeled and unlabeled recombinant proteins were generated control) were selected so that PCR amplification of genomic DNA
from 2 g of plasmid DNA using the TnT Quick Coupled Transcrip- yielded fragments containing an intron, while amplification of re-
tion/Translation System (Promega) in the presence or absence of verse-transcribed cDNA yielded nonintron-containing fragments.
S35-L-methionine (ICN Biochemicals). Coimmunoprecipitation was We set up a competitive quantitative assay as previously described
performed as previously described with minor modifications (Klei- (Siebert and Larrick, 1992). After an initial “hot start” at 98C for 2
man and Manley, 1999). In brief, 15 l of in vitro-translated CRX, min, 34 amplification cycles (94C for 30 s, 65C for 30 s, 72C for
NRL, ataxin-7, and/or Myc-tag product were gently mixed in 100 l 1 min) with 1.5 Ci of dCTP-(-33P) (3000 Ci/mM; NEN) per reaction
of Binding Buffer (1 PBS, 0.01% NP40) at 30C for 2 hr. Each were performed. After acrylamide gel electrophoresis, we derived
reaction mix was then incubated with 2 l of the anti-CRX antibody an intensity ratio on a Phosphor-Imager (Molecular Dynamics).
p261 or anti-myc antibody for 2 hr at 4C, followed by overnight
coupling with 50 l of Protein A-Sepharose beads (Pharmacia). Pro- Northern Blot Analysis
teins bound to the antibody-Protein A beads were washed five times Retinal RNA (5g per sample set) was fractionated in 0.8% denatur-
(50 mM Tris-Cl [pH 7.5], 150 mM NaCl, 0.5% Triton X-100), eluted ing agarose gels, transferred in 6 SSC, and probed with random
from the beads using a SDS gel-loading buffer, resolved on a 11% hexamer-labeled cDNA fragments in a 50% formamide-based hy-
SDS-polyacrylamide gel, and visualized after treating with Amplify bridization buffer at 42C. Band intensities were determined by scan-
(Amersham). ning on a Phosphor-Imager (Molecular Dynamics) and were normal-
ized to densitometric measurements of ethidium-stained 18S RNA
HEK293T Cell Transfections, Immunofluorescence, on a Gel Doc 2000 (Biorad).
and Transactivation Assays
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